However, silencing Rab27a or TRAF3IP2 had no significant effects on non-malignant cells like MSCs, suggesting that targeting Rab27aor TRAF3IP2 affect only the tumor cells but not the normal mesenchyml cells. Here, TRAF3IP2 is linked to neoplasm.